Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties

Details for Australian Patent Application No. 2011202249 (hide)

Owner Novartis Vaccines and Diagnostics, Inc.

Inventors Cai, Shaopei; Chou, Joyce; Harwood, Eric; Machajewski, Timothy; Ryckman, David; Shang, Xiao; Zhu, Shuguang

Agent FB Rice

Pub. Number AU-A-2011202249

Parent 2004288692

Filing date 16 May 2011

Wipo publication date 2 June 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4375 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

2 June 2011 Application Open to Public Inspection

  Published as AU-A-2011202249

2 June 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011202250-Protective End Fitting For A Post

2011202248-Method of remotely controlling a materials handling vehicle